Enzalutamide trials for Prostate Adenocarcinoma

All Enzalutamide trials · All Prostate Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Enzalutamide for Prostate Adenocarcinoma

• A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
  NCT05726292 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
  NCT06257693 · Phase: Phase 1 · Ages: 21 Years and older · Sex: Male · 10 locations
• Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
  NCT06499870 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Enzalutamide for Prostate Adenocarcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.